Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.

Stahel, R A; Jost, L M; Cerny, T; Pichert, G; Honegger, H; Tobler, A; Jacky, E; Fey, M; Platzer, E

Stahel, R A; Jost, L M; Cerny, T; Pichert, G; Honegger, H; Tobler, A; Jacky, E; Fey, M; Platzer, E.

Affiliation

Stahel RA; Department of Medicine, University Hospital, Zürich, Switzerland.

J Clin Oncol ; 12(9): 1931-8, 1994 Sep.

Article in En | MEDLINE | ID: mdl-7521907

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Bone Marrow Transplantation; Granulocyte Colony-Stimulating Factor/therapeutic use; Lymphoma/therapy; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carmustine/administration & dosage; Carmustine/adverse effects; Combined Modality Therapy; Cyclophosphamide/administration & dosage; Cyclophosphamide/adverse effects; Etoposide/administration & dosage; Etoposide/adverse effects; Female; Filgrastim; Granulocyte Colony-Stimulating Factor/adverse effects; Humans; Leukocyte Count; Lymphoma/mortality; Male; Middle Aged; Neutropenia/blood; Neutropenia/chemically induced; Neutropenia/therapy; Neutrophils; Prospective Studies; Recombinant Proteins/adverse effects; Recombinant Proteins/therapeutic use; Survival Rate; Transplantation, Autologous

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Granulocyte Colony-Stimulating Factor / Bone Marrow Transplantation / Lymphoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1994 Type: Article Affiliation country: Switzerland

Search on Google

XML

PubMed Links